Skip to search formSkip to main contentSkip to account menu

crofelemer 125 MG Delayed Release Oral Tablet [Fulyzaq]

Known as: CROFELEMER 125 mg ORAL TABLET, COATED [FULYZAQ], Fulyzaq 125 MG Delayed Release Oral Tablet 
National Institutes of Health

Related topics

Related topics

2 relations
Delayed Release Oral Tabletcrofelemer

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Crofelemer (Fulyzaq™) Approved to Treat Noninfectious Diarrhea in HIV-Infected Adults
• Approved by the FDA on December 31, 2012 • Compound originally studied for respiratory syncytial virus • Mechanism of Action… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)